CBC Pharma IPO Details

CBC Pharma IPOCBC Pharma IPO description – CBC Pharma is engaged in the business of marketing pharmaceutical critical care & health care products. It has obtained necessary approvals from FDA for getting the formulations manufactured from contract manufacturers on Loan license or on principle to principle basis.

At present, it has a wide range of products portfolio of pharmaceutical formulation including IV & IM range injections, few tablets to cater the domestic & export markets. The company has established presence in major therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology etc. It is also engaged in promoting and marketing of Active Pharmaceuticals Ingredients (API’s) in India.

Its core strength lies in marketing & also getting its approved formulation manufactured through Contract Manufacturers and marketing of therapeutic formulations under its own brand and trading of various API’s, which it commercializes through marketing network across geographies and by developing relationships with pharmaceutical companies of different sizes.

Promoters of CBC Pharma – Mr Hemant Chandravadan Bhagat and Mr Pranav Hemant Bhagat
CBC Pharma IPO details
Subscription Dates 31 January – 6 February 2020
Price Band INR51 per share
Fresh issue 2,000,000 shares (INR10.2 crore)
Offer For Sale Nil
Total IPO size 2,000,000 shares (INR10.2 crore)
Minimum bid (lot size) 2,000 shares
Face Value  INR10 per share
Retail Allocation 50%
Listing On BSE SME platform

CBC Pharma’s financial performance (in INR lakh)

  FY2017 FY2018 FY2019 4M FY2020
Revenue 9,028.1 9,773.4 10,671.8 3,344.5
Expenses 8,936.8 9,620.2 10,583.3 3,311.5
Net income 66.0 103.4 62.6 24.9

Registrar of CBC Pharma

Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai – 400 083

: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: http://www.linkintime.co.in

Valuation of CBC Pharma IPO (FY2019)

Earnings Per Share (EPS): INR1.17
Price/Earnings (PE ratio): 43.59
Return on Net Worth (RONW): 4.71%
Net Asset Value (NAV): INR25.22 per share (as of 31 July 2019)

CBC Pharma IPO Subscription Details


Subscription (no. of times)

Day 1


Day 2


Day 3


Day 4 1.01
Day 5


CBC Pharma Contact Details

Chandra Bhagat Pharma Limited
323-F Bhagat Bhuvan
Dr. Ambedkar Road, Matunga (East) Mumbai- 400019

+91 22 2414 6154
Email: [email protected]
Website: www.cbcpharma.com

CBC Pharma IPO Allotment Status

CBC Pharma IPO allotment status is now available on Link Intime’s website. Click on this link to get allotment status.

Listing Performance of CBC Pharma

IPO Opening Date: 31 January 2020
IPO Closing Date: 6 February 2020
Finalisation of Basis of Allotment: 11 February 2020
Initiation of refunds: 13 February 2020
Transfer of shares to demat accounts: 13 February 2020
Listing Date: 14 February 2020
Opening Price on BSE SME: INR51.7 per share (up 1.37% from IPO price)
Closing Price on BSE SME: INR51.75 per share (up 1.47% from IPO price)



Please enter your comment!
Please enter your name here

Brokerage-free IPO Investing